Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISA 2020 | DISCOVERY: cardiac amyloidosis screening study

Mathew Maurer, MD, Columbia University, New York, NY, discusses the results of the DISCOVERY screening study (NCT02252653), which investigated the prevalence of TTR mutations in patients suspected of having cardiac amyloidosis. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).